Please login to the form below

Not currently logged in
Email:
Password:

PharmaLex strengthens international team

Consultancy group appoints Adrian Pencak

Adrian PencakPharmaLex Group has appointed new executive vice president, business development and marketing in the form of Adrian Pencak.

Pencak joins the German consultancy group following over 25 years’ global business development, marketing and operations experience, spanning the life sciences and healthcare sectors.

He said: “I am very excited to have joined the PharmaLex management team as we are a company with ambitious growth targets as well as extremely high standards of services.

“I’m looking forward to playing a key role in our continued growth and success, with a special focus on the US.”

He joins the group from ICON, where he was vice president, global business development early phase services.

Dr Thomas Dobmeyer, chief executive officer at PharmaLex, said: “Adrian’s appointment demonstrates our commitment to developing our global infrastructure and sales.

“Alongside his strong business development experience, Adrian’s background in the IT space will also support our artificial intelligence and innovative led services.”

24th October 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics